T2 Biosystems, Inc.·4

Oct 11, 5:00 PM ET

CUMMING JOHN W 4

4 · T2 Biosystems, Inc. · Filed Oct 11, 2023

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-15+2,6005,256 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-152,6000 total
    Common Stock (2,600 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On October 11, 2022, the reporting person was granted 2,600 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4